Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PRF TechnologiesPRFX -2.38%22 Market Cap is $3.26 Mil as of Sep. 09, 2026. GuruFocus rates PRFX with a GF Score™ of 22/100. The stock has 1 warning sign investors should review. Among 1,023 Drug Manufacturers companies, PRF Technologies ranks worse than 92.67% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). PRF Technologies's share price for the quarter that ended in Jun. 2026 was $1.38. PRF Technologies's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 3.04 Mil. Therefore, PRF Technologies's market cap for the quarter that ended in Jun. 2026 was $4.20 Mil.
PRF Technologies's quarterly market cap
declined
from Jun. 2025 ($2.90 Mil) to Dec. 2025 ($2.67 Mil) but then
increased
from Dec. 2025 ($2.67 Mil) to Jun. 2026 ($4.20 Mil).
PRF Technologies's annual market cap
increased
from Dec. 2023 ($4.62 Mil) to Dec. 2024 ($4.93 Mil) but then
declined
from Dec. 2024 ($4.93 Mil) to Dec. 2025 ($2.67 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PRF Technologies's Enterprise Value for Today is $-7.43 Mil.
PRF Technologies (NAS:PRFX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PRF Technologies Market Cap Related Terms
PRF Technologies Market Cap Historical Data
* Premium members only.
The historical data trend for PRF Technologies's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, PRF Technologies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PRF Technologies Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PRF Technologies's Market Cap distribution charts can be found below:
* The bar in red indicates where PRF Technologies's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
PRF Technologies's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PRF Technologies (PRFX) has a Market Cap of $3.26 Mil as of Sep. 09, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PRF Technologies and its competitors. According to the industry distribution chart, PRF Technologies ranks #948 out of 1023 companies in the Drug Manufacturers industry, placing it in the top 92.7%.
Is PRF Technologies' Market Cap too high?
PRF Technologies' current Market Cap is $3.26 Mil. The Drug Manufacturers industry median Market Cap is 237.58. PRF Technologies' value of $3.26 Mil is 98.6% below this industry median. Based on the distribution chart, PRF Technologies ranks #948 out of 1023 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, PRF Technologies has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does PRF Technologies' Market Cap compare to CTTH and UPC?
According to the Drug Manufacturers industry distribution chart, PRF Technologies ranks #948 out of 1023 companies for Market Cap. This places PRF Technologies in the lower half of its industry. The industry median Market Cap is 237.58. PRF Technologies' value of $3.26 Mil is 98.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 237.58, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PRF Technologies's current Market Cap of $3.26 Mil is 98.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PRF Technologies and its competitors. For the Drug Manufacturers industry, the median Market Cap is 237.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PRF Technologies's current Market Cap is $3.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PRF Technologies stock overvalued right now?
PRF Technologies (PRFX) has a current Market Cap of $3.26 Mil. The current Market Cap is $3.26 Mil and 98.6% below the Drug Manufacturers industry median of 237.58. PRF Technologies' overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For PRF Technologies (PRFX), the current Market Cap is $3.26 Mil as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.
22GF Score
Get the complete analysis for PRFX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRFX has been successfully added to your 
